公司資料
Masimo 股價、新聞與催化劑
- 股票代碼:
- MASI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
178.78 USD (+0.03%)
收盤價
最後更新: 2026年6月3日
9.36B USD
市值
股價為何變動
Current closing-price context is not available for MASI.
公司概覽
業務概覽
Masimo is a medical technology company focused on noninvasive monitoring, pulse oximetry, and connected healthcare devices. Its products are used in hospitals and consumer health settings for real-time patient monitoring.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Masimo has a global footprint in patient monitoring and consumer health. It sits in medtech rather than biotechnology.
商業模式特徵
The company earns revenue through monitoring devices, consumables, and connected-health solutions. Investors follow product adoption, reimbursement, hospital penetration, and the role of consumer-health assets in the overall story.
生技產業定位
Masimo sits outside biotech but within the healthcare innovation stack. Its stock is driven by device adoption, technology execution, and litigation or strategic issues more than by drug events.
未來催化劑
- Masimo’s catalysts are hospital-monitoring adoption, consumer-health recovery, and continued rollout of the connected monitoring platform. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。